Biosensor comprising a plurality of functionalized sets of carbon atoms in the sp2 hybridisation state, preparation method thereof and use thereof, in particular for the detection of ecotoxicological risks

US2024011069A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024011069-A1
Application numberUS-202318323489-A
CountryUS
Kind codeA1
Filing dateMay 25, 2023
Priority dateMay 25, 2022
Publication dateJan 11, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a biosensor comprising a plurality of functionalized sets of carbon atoms in the sp2 hybridisation state, its method of preparation and its use, in particular for the detection of ecotoxicological risks, in particular the determination of the toxicity of substances present in an aqueous medium, as well as to the corresponding determination method.

First claim

Opening claim text (preview).

1 . A biosensor comprising: a first set A of carbon atoms in the sp 2 hybridisation state, said set being in contact with: a plurality of compounds of the following formula (I 1 ): (R-L 1 -W) n —V-L 2 -X—Y  (I 1 ) and optionally, a plurality of compounds of the following formula (II 1 ): (R-L 1 -W) n —V-L 2 -X—Z  (II 1 ), a second set B of carbon atoms in the sp 2 hybridisation state, said set being in contact with: a plurality of compounds of the following formula (I 2 ): (R-L 1 W) n —V-L 1 -X—Y  (I 2 ), and a plurality of compounds of the following formula (II 2 ): (R-L 1 -W) n —V-L 2 -X—Z  (II 2 ), at least one third set C of carbon atoms in the sp 2 hybridisation state, said set being in contact with: a plurality of compounds of the following formula (I 3 ): (R-L 1 -W) n —V-L 2 -X—Y  (I 3 ), and a plurality of compounds of the following formula (II 3 ): (R-L 1 -W) n —V-L 2 -X—Z  (II 3 ), with, independently of the carbon set A to C and of the compound of the formula (I) to (II): n is equal to 1, 2, or 3, in particular 3; V represents, for all n, —C(H) 3-n — or: when n is equal to 2, —C(H)═, C being in this case bonded to L 2 by a double bond; when n is equal to 1, —C≡, C being in this case bonded to L 2 by a triple bond; R is an aromatic hydrocarbon comprising from 2 to 6 condensed aromatic cycles; L 1 is a C1-C12 alkanediyl group; W represents a single bond, an arenediyl group, a heteroarenediyl group or a —O—Ar 1 — group where Ar 1 is an arene or a heteroarene; L 2 is a group of formula (A) as follows, -(L 2a ) i -(L 2b ) j - wherein: i and j are independently of each other selected from 0 and 1, with i+j=1 or 2; L 2a is a C 1 -C 12 alkanediyl, C 2 -C 12 alkenediyl or C 2 -C 12 alkynediyl group; L 2b is an arenediyl group, a heteroarenediyl group or a group —O—Ar 2 — where Ar 2 is an arene or a heteroarene; X is a —C(═O)N—, —C(═O)O— or —C(═O)S— group; Y is an antibacterial antibody or a lectin; Z is an antibacterial peptide; and where the sets A, B and C are such that: the set A is free of compounds of the formula (II 1 ) or the molar ratio of the amount of compounds of the formula (II 1 ) to that of compounds of the formula (I 1 ) is less than 0.1; in the set B, the molar ratio of the amount of compounds of the formula (I 2 ) to that of compounds of the formula (II 2 ) being from 0.66 to 1.5, for example about 1.0; and in the set C, the molar ratio of the amount of compounds of the formula (I 3 ) to that of compounds of the formula (II 3 ) being from 0.33 to 0.66, for example about 0.5. 2 . The biosensor of claim 1 , comprising: at least two sets B of carbon atoms in the sp 2 hybridisation state, for which the molar ratio of the amount of compounds of the formula (I 2 ) to that of compounds of the formula (II 2 ), being from 0.66 to 1.5, differs; and/or at least two sets C of carbon atoms in the sp 2 hybridisation state, for which the molar ratio of the amount of compounds of the formula (I 3 ) to that of compounds of the formula (II 3 ), being from 0.33 to 0.66, differs. 3 . The biosensor according to claim 1 , wherein said sets A, B and C of carbon atoms in the sp 2 hybridisation state are independently selected from graphene, graphene oxide, graphite, carbon nanotubes, fullerenes and fullerites, said sets being in particular graphene, more particularly in the form of sheets or flakes. 4 . The biosensor according to claim 1 , wherein R, L 1 , W, n, V, L 2 , X, Y and Z are the same in the compounds of the formula (I) and (II), for the sets A, B and C. 5 . The biosensor according to claim 1 , wherein: R is the 1-pyrenyl or the 2-pyrenyl, in particular the 1-pyrenyl; L 1 is a C 2 -C 8 alkanediyl group; and/or W represents a group —O—Ar 1 — where Ar 1 is an arene or a heteroarene, in particular a benzene; and/or i and j are equal to 1; and/or L 2a is a C 2 -C 12 alkynediyl group, in particular —C≡C—; and/or L 2b is an arenediyl group, in particular a benzenediyl; and/or R, L 1 , W, V and L 2 are as defined by the following formula: 6 . The biosensor according to claim 1 , wherein: Y is selected from the antibodies against gram-positive bacteria, the antibodies against gram-negative bacteria, in particular the antibodies directed against one or more natural environmental and/or industrial effluent bacteria, the antibodies being more particularly antibodies against Escherichia coli , or in particular the antibodies directed against one or more luminescent bacteria, more particularly Vibrio fischeri, Vibrio harveyi, Photobacterium phosphoreum, Shewanella hanedai, Shewanella woodyi , and Photorhabdus luminescens; Z is selected from cecropins, defensins, magainins and dermaseptins, Z being in particular a cecropin. 7 . The biosensor according to claim 1 , wherein the density of compounds of the formulae (I) and (II) on the surface of the sets of carbon atoms in the sp 2 hybridisation state is from about 1 of such compounds per 300 nm2 area to about 1 of such compound per 2 nm 2 area, in particular about 1 compound per about 2.7 nm 2 area. 8 . A use of a biosensor according to claim 1 for the determination of the toxicity of substances present in an aqueous medium. 9 . A method for determining the toxicity of substances present in an aqueous medium, comprising the following steps: a) Contacting the sets A, B and C of carbon atoms in the sp 2 hybridisation state of the biosensor according to claim 1 , with bacteria capable of being recognized by the antibacterial antibodies Y or of interacting with the lectins Y of said sets to obtain sets on which said bacteria are immobilized; b) Contacting the sets as obtained in step a) with said aqueous medium; c) Assessing the viability of said bacteria on the sets as obtained in step b). 10 . The method according to claim 9 , wherein: the groups Y are selected from the antibodies directed against one or more bacteria likely to be contained in the aqueous medium for which the measurement of the presence of toxic substances is desired; or the groups Y are selected from the antibodies directed against one or more luminescent bacteria, the bacteria of step a) are said one or more luminescent bacteria, and the assessment of the viability of said bacteria according to step c) is carried out by irradiation with a UV lamp and then measurement of the fluorescence, in particular with a camera. 11 . The method according to claim 9 , wherein the assessment of the viability of the bacteria according to step c) is done by measuring the mass of said sets A, B and C.

Assignees

Inventors

Classifications

  • C12Q1/04Primary

    Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title

  • Isolated enzymes; Isolated proteins (peptides A01N37/46) · CPC title

  • Disinfectants; Antimicrobial compounds or mixtures thereof · CPC title

  • Bacteria · CPC title

  • Cationic antimicrobial peptides, e.g. defensins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024011069A1 cover?
The present invention relates to a biosensor comprising a plurality of functionalized sets of carbon atoms in the sp2 hybridisation state, its method of preparation and its use, in particular for the detection of ecotoxicological risks, in particular the determination of the toxicity of substances present in an aqueous medium, as well as to the corresponding determination method.
Who is the assignee on this patent?
Commissariat Energie Atomique
What technology area does this patent fall under?
Primary CPC classification C12Q1/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jan 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).